DiaMedica Therapeutics Inc. (17) | Business Operations (3)
- Second Amendment to GPEx Development and Manufacturing Agreement dated as of October 22, 2018 between DiaMedica Therapeutics Inc. and Catalent Pharma Solutions, LLC (Filed With SEC on March 23, 2020)
- Specimen Certificate representing Voting Common Shares of DiaMedica Therapeutics Inc (Filed With SEC on June 4, 2019)
- Form of Indemnification Agreement between DiaMedica Therapeutics Inc. and each Director and Officer (Filed With SEC on June 4, 2019)
